PROTALIX BIOTHERAPEUTICS INC - COM (PLX)

CUSIP: 74365A101

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Equity / COM
Total 13F shares
10,757,108
Share change
+1,927,388
Total reported value
$5,050,159
Put/Call ratio
15%
Price per share
$0.47
Number of holders
26
Value change
+$914,126
Number of buys
11
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 74365A101?
CUSIP 74365A101 identifies PLX - PROTALIX BIOTHERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PROTALIX BIOTHERAPEUTICS INC - COM (PLX) as of Q2 2019

As of 30 Jun 2019, PROTALIX BIOTHERAPEUTICS INC - COM (PLX) was held by 26 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,757,108 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, Fosun International Ltd, Opaleye Management Inc., CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, J. Goldman & Co LP, SG Americas Securities, LLC, GROUP ONE TRADING, L.P., BRIDGEWAY CAPITAL MANAGEMENT INC, UBS Group AG, and MEITAV DASH INVESTMENTS LTD. This page lists 26 institutional shareholders reporting positions in this security for the Q2 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.